Entry to the us
April 2, 2024by Brill
Brill announces entry into the US pharmaceutical market starting with new disruptive medical device in ophthalmology of its own development Miami, FL, April 2nd 2024 – BRILL S.L. is a rising pharmaceutical company dedicated to the development, manufacturing and marketing of innovative medical solutions covering essential clinical needs in ophthalmology. Brill is headquartered in Miami and...
